Back

VLDL induces EZH2/PRC2 complex-mediated cellular senescence in metabolic syndrome to enhance cardiotoxicity

31 August 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Novel insights into ageing and senescence Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Doctor Yi-Hsiung Lin

Kaohsiung Medical University Hospital, Kaohsiung (Taiwan)

Photo
Professor Hsiang-Chun Lee

Kaohsiung Medical University Gangshan Hospital, Kaohsiung (Taiwan)

8 More presentations in this session

Presentation thumbnail
The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
The effect of CD38 inhibition in age-associated vascular dysfunction
Doctor Y. Puspitasari (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
The role of cellular senescence in aortic dissection
Doctor E. Nakao (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Non-cell-autonomous effects of arginase-II in macrophages on cardiomyocytes in aging
Doctor D. Potenza (Fribourg, CH)
Abstract Slides Video
Presentation thumbnail
Sirt5 as a mediator of endothelial and vascular dysfunction: potential therapeutic target in aging-related vascular diseases
Doctor K. Yang (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into ageing and senescence

The Event

Event poster

ESC Congress 2024

31 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Presentation
VLDL-induces lipid accumulation and modulates alternative splicing of VLDLR in cardiomyocytes
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources